ChroMedX Corp. is pleased to report that it has engaged Hochuen International Corp. to produce an enhanced version of its prototype HemoPalm cartridges.
ChroMedX Corp. has entered into a development agreement with Hochuen International Corp. to produce the enhanced version of its HemoPalm cartridges by machining as a preliminary step, which will be followed by injection molding.
ChroMedX previously announced its development program with McMaster University’s Manufacturing Research Institute (MMRI), when fabrication of a prototype HemoPalm cartridge, a key component of the HemoPalm analysis system, was completed. As a result of the McMaster work, the Company has developed an improved cartridge which is smaller and will reduce manufacturing costs.
In 2012, Hochuen was certified with ISO13485, and has served the biomedical and life science community with high quality biological testing and diagnostics consumables and device components. Hochuen attracts world class talents with microfluidics and medical devices experience. It also serves as a microfluidics design house with the following design capabilities: micro mixing, micro valves, micro pumps and integrated devices.